Cationic amylose-encapsulated bovine hemoglobin as a nanosized oxygen carrier

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9425-9433

  Gao, Wei ^a,b   Sha, Baoyong ^a   Zou, Wei ^c   Liang, Xuan ^b   Meng, Xiangzhong ^b   Xu, Hao ^b   Tang, Jun ^b   Wu, Daocheng ^a   Xu, Lixian ^b   Zhang, Hui ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

Blood; Micelles; Nanoparticle; Starch

Indexed keywords

AVERAGE DIAMETER; BOVINE HEMOGLOBIN; COMBINED METHOD; DEGREE OF SUBSTITUTION; DRUG-LOADING EFFICIENCY; ELECTROSTATIC ADHESION; ENTRAPMENT EFFICIENCY; ETHERIFICATION REACTIONS; FOURIER TRANSFORM INFRARED SPECTROPHOTOMETRY; FT-IR SPECTRUM; FTIR; HEMOGLOBIN-BASED OXYGEN CARRIERS; HEMORRHAGIC SHOCK; HILL COEFFICIENT; LUNG INJURY; NANO-SIZED; OXYGEN CARRIER; PBS SOLUTION; POLYDISPERSITY INDICES; PROTON NUCLEAR MAGNETIC RESONANCE; QUATERNARY AMMONIUM SALT; REVERSE MICELLES; THERAPEUTIC EFFECTS; UV-VISIBLE SPECTROPHOTOMETER;

ADHESION; AMMONIUM COMPOUNDS; BLOOD; CATALYST ACTIVITY; FOURIER TRANSFORMS; HEMOGLOBIN; MICELLES; NANOPARTICLES; NUCLEAR MAGNETIC RESONANCE; POLYDISPERSITY; SPECTROPHOTOMETRY; STARCH; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

OXYGEN;

AMYLOSE; CATIONIC AMYLOSE; CATIONIC AMYLOSE ENCAPSULATED HEMOGLOBIN; NANOCARRIER; OXYGEN; QUATERNARY AMMONIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG SYNTHESIS; ETHERIFICATION; HEMORRHAGIC SHOCK; INFRARED SPECTROSCOPY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REVERSE MICELLE; STATIC ELECTRICITY; SUBSTITUTION REACTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; ZETA POTENTIAL;

AMYLOSE; ANIMALS; BLOOD PRESSURE; CATIONS; CATTLE; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; HEMOGLOBINS; LUNG; NANOPARTICLES; OXYGEN; PARTICLE SIZE; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, HEMORRHAGIC; SPECTROPHOTOMETRY, ULTRAVIOLET;

BOVINAE; RATTUS;

EID: 80053600174     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.046     Document Type: Article

References (56)

1. Patton J.N., Palmer A.F. Physical properties of hemoglobin-poly(acrylamide) hydrogel-based oxygen carriers: effect of reaction pH. Langmuir 2006, 22:2212-2221.
2. Chang T.M.S. Artificial cells: biotechnology, nanomedicine, regenerative medicine, blood substitutes, bioencapsulation, cell/stem cell therapy 2007, World Scientific, Hackensack, NJ.
3. Squires J.E. Artificial blood. Science 2002, 295:1002-1005.
4. Gaucher-Di Stasio C., Paternotte E., Prin-Mathieu C., Reeder B.J., Poitevin G., Labrude P., et al. The importance of the effect of shear stress on endothelial cells in determining the performance of hemoglobin based oxygen carriers. Biomaterials 2009, 30:445-451.
5. Chang T.M.S. Blood substitutes based on nanobiotechnology. Trends Biotechnol 2006, 24:372-377.
6. Piras A.M., Dessy A., Chiellini F., Chiellini E., Farina C., Ramelli M., et al. Polymeric nanoparticles for hemoglobin-based oxygen carriers. Biochim Biophys Acta 2008, 1784:1454-1461.
7. Tsuchida E., Sou K., Nakagawa A., Sakai H., Komatsu T., Kobayashi K. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry. Bioconjug Chem 2009, 20:1419-1440.
8. Djordjevich L., Miller I.F. Synthetic erythrocytes from lipid encapsulated hemoglobin. Exp Hematol 1980, 8:584-592.
9. Sakai H., Horinouchi H., Masada Y., Takeoka S., Ikeda E., Takaori M., et al. Metabolism of hemoglobin-vesicles (artificial oxygen carriers) and their influence on organ functions in a rat model. Biomaterials 2004, 25:4317-4325.
10. Sakai H., Sou K., Horinouchi H., Kobayashi K., Tsuchida E. Review of hemoglobin-vesicles as artificial oxygen carriers. Artif Organs 2009, 33:139-145.
11. Ahmed F., Photos P.J., Discher D.E. Polymersomes as viral capsid mimics. Drug Develop Res 2006, 67:4-14.
12. LoPresti C., Lomas H., Massignani M., Smart T., Battaglia G. Polymersomes: nature inspired nanometer sized compartments. J Mater Chem 2009, 19:3576-3590.
13. Patton J.N., Palmer A.F. Engineering temperature-sensitive hydrogel nanoparticles entrapping hemoglobin as a novel type of oxygen carrier. Biomacromolecules 2005, 6:2204-2212.
14. Degim I.T., Celebi N. Controlled delivery of peptides and proteins. Curr Pharm Design 2007, 13:99-117.
15. Santander-Ortega M.J., Stauner T., Loretz B., Ortega-Vinuesa J.L., Bastos-Gonzalez D., Wenz G., et al. Nanoparticles made from novel starch derivatives for transdermal drug delivery. J Control Release 2010, 141:85-92.
16. Yu H.L., Huang Q.R. Enhanced in vitro anti-cancer activity of curcumin encapsulated in hydrophobically modified starch. Food Chem 2010, 119:669-674.
17. Simi C.K., Emilia Abraham T. Hydrophobic grafted and cross-linked starch nanoparticles for drug delivery. Bioprocess Biosyst Eng 2007, 30:173-180.
18. Cole A.J., David A.E., Wang J.X., Galban C.J., Hill H.L., Yang V.C. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials 2011, 32:2183-2193.
19. Jain A.K., Khar R.K., Ahmed F.J., Diwan P.V. Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier. Eur J Pharm Biopharm 2008, 69:426-435.
20. Deutel B., Greindl M., Thaurer M., Bernkop-Schnuerch A. Novel insulin thiomer nanoparticles: in vivo evaluation of an oral drug delivery system. Biomacromolecules 2008, 9:278-285.
21. Lin Y.H., Chen C.T., Liang H.F., Kulkarni A.R., Lee P.W., Chen C.H., et al. Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology 2007, 18:1-11.
22. Nan A. Multifunctional nanocarrier for image-guided delivery of bioactive agents. Nanomedicine (Lond) 2007, 2:739-743.
23. Gupta A.K., Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 2005, 26:3995-4021.
24. Thevis M., Opfermann G., Schanzer W. Determination of the plasma volume expander hydroxyethyl starch in human urine. Deut Z Sportmed 2001, 52:316-320.
25. Asskali F., Warnken U., Forster H. Acetyl starch, a possible alternative to hydroxyethyl starch as a plasma volume expander. Deut Med Wochenschr 2001, 126:1-6.
26. Wittemann A., Henzler K., Breininger E., Ballauff M., Rosenfeldt S. Adsorption of bovine hemoglobin onto spherical polyelectrolyte brushes monitored by small-angle x-ray scattering and fourier transform infrared spectroscopy. Biomacromolecules 2007, 8:3674-3681.
27. Slattery C.J., Kavakli I.H., Okita T.W. Engineering starch for increased quantity and quality. Trends Plant Sci 2000, 5:291-298.
28. Onofre F.O., Mendez-Montealvo G., Wang Y.J. Sustained release properties of cross-linked corn starches with varying amylose contents in monolithic tablets. Starch-Starke 2010, 62:165-172.
29. Liu H., Corke H., Ramsden L. Functional properties and enzymatic digestibility of cationic and cross-linked cationic ae, wx, and normal maize starch. J Agric Food Chem 1999, 47:2523-2528.
30. Kinugasa T., Kondo A., Mouri E., Ichikawa S., Nakagawa S., Nishii Y., et al. Effects of ion species in aqueous phase on protein extraction into reversed micellar solution. Sep Purif Technol 2003, 31:251-259.
31. Orlich B., Schomacker R. Enzyme catalysis in reverse micelles. Adv Biochem Eng Biotechnol 2002, 75:185-208.
32. Budker V.G., Slattum P.M., Monahan S.D., Wolff J.A. Entrapment and condensation of DNA in neutral reverse micelles. Biophys J 2002, 82:1570-1579.
33. Park L.C., Maruyama T., Goto M. DNA hybridization in reverse micelles and its application to mutation detection. Analyst 2003, 128:161-165.
34. Naoe K., Noda K., Kawagoe M., Imai M. Higher order structure of proteins solubilized in AOT reverse micelles. Colloid Surf B 2004, 38:179-185.
35. Kavallauskaite R., Klimaviciute R., Zemaitaitis A. Factors influencing production of cationic starches. Carbohyd Polym 2008, 73:665-675.
36. Wang Y.B., Xie W.L. Synthesis of cationic starch with a high degree of substitution in an ionic liquid. Carbohyd Polym 2010, 80:1172-1177.
37. Bendoraitiene J., Kavaliauskaite R., Klimaviciute R., Zemaitaitis A. Peculiarities of starch cationization with glycidyltrimethylammonium chloride. Starch-Starke 2006, 58:623-631.
38. Tamamushi B., Watanabe N. The formation of molecular aggregation structures in ternary system: aerosol OT/water/iso-octane. Colloid Polym Sci 1980, 258:174-178.
39. Manchanda R., Nimesh S. Controlled size chitosan nanoparticles as an efficient, biocompatible oligonucleotides delivery system. J Appl Polym Sci 2010, 118:2071-2077.
40. Rameez S., Alosta H., Palmer A.F. Biocompatible and biodegradable polymersome encapsulated hemoglobin: a potential oxygen carrier. Bioconjug Chem 2008, 19:1025-1032.
41. Zhao J., Liu C.S., Yuan Y., Tao X.Y., Shan X.Q., Sheng Y., et al. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. Biomaterials 2007, 28:1414-1422.
42. Zijlstra W.G., Buursma A. Spectrophotometry of hemoglobin: absorption spectra of bovine oxyhemoglobin, deoxyhemoglobin, carboxyhemoglobin, and methemoglobin. Comp Biochem Phys B 1997, 118:743-749.
43. Chang T.M.S. Red blood cell substitutes. Best Pract Res Cl Ha 2000, 13:651-667.
44. Meng F.T., Ma G.H., Liu Y.D., Qiu W., Su Z.G. Microencapsulation of bovine hemoglobin with high bio-activity and high entrapment efficiency using a W/O/W double emulsion technique. Colloid Surf B 2004, 33:177-183.
45. Arifin D.R., Palmer A.F. Polymersome encapsulated hemoglobin: a novel type of oxygen carrier. Biomacromolecules 2005, 6:2172-2181.
46. Yu D.M., Xiao S.Y., Tong C.Y., Chen L., Liu X.M. Dialdehyde starch nanoparticles: preparation and application in drug carrier. Chin Sci Bull 2007, 52:2913-2918.
47. Chen L.H., Tianqing L.Q. Interaction behaviors between chitosan and hemoglobin. Int J Biol Macromolecules 2008, 42:441-446.
48. Liu C.S., Sheng Y., Yuan Y., Zhang X.L., Shan X.Q., Xu F. Porosity and semipermeability of hemoglobin-loaded polymeric nanoparticles as potential blood substitutes. J Biomed Mater Res B 2009, 91B:631-642.
49. Tsuchida E., Sakai H., Sato A., Sobolewski P., Takeoka S., Frangos J.A., et al. NO and CO binding profiles of hemoglobin vesicles as artificial oxygen carriers. Bba-Proteins Proteom 2008, 1784:1441-1447.
50. Doucet D., Badami C., Palange D., Bonitz R.P., Lu Q., Xu D.Z., et al. Estrogen receptor hormone agonists limit trauma hemorrhage shock-induced gut and lung injury in rats. Plos One 2010, 5:7.
51. Masuno T., Moore E.E., Cheng A.M., Moore P.K., Grant A.R., Johnson J.L. Prehospital hemoglobin-based oxygen carrier resuscitation attenuates postinjury acute lung in jury. Surgery 2005, 138:335-341.
52. Chang T.M.S., Varma R. Effect of a single replacement of one of ringer lactate, hypertonic saline/dextran, 7 g% albumin, stroma-free hemoglobin, o-raffinose polyhemoglobin or whole-blood on the long-term survival of unanesthetized rats with lethal hemorrhagic-shock after 67% acute blood-loss. Biomat Artif Cell Im 1992, 20:503-510.
53. Kasper S.M., Walter M., Grune F., Bischoff A., Erasmi H., Buzello W. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery. Anesth Analg 1996, 83:921-927.
54. Shono S., Kinoshita M., Takase B., Nogami Y., Kaneda S., Ishihara M., et al. Intraosseous transfusion with liposome-encapsulated hemoglobin improves mouse survival after hypohemoglobinemic shock without scavenging nitric oxide. Shock 2011, 35:45-52.
55. Creteur J., Vincent J.L. Potential uses of hemoglobin-based oxygen carriers in critical care medicine. Crit Care Clin 2009, 25:311-324.
56. Wettstein R., Tsai A.G., Erni D., Winslow R.M., Intaglietta M. Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters. Crit Care Med 2003, 31:1824-1830.